These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23232498)

  • 1. True and apparent inhibition of amyloid fibril formation.
    Martins PM
    Prion; 2013; 7(2):136-9. PubMed ID: 23232498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insoluble Off-Pathway Aggregates as Crowding Agents during Amyloid Fibril Formation.
    Crespo R; Villar-Alvarez E; Taboada P; Rocha FA; Damas AM; Martins PM
    J Phys Chem B; 2017 Mar; 121(10):2288-2298. PubMed ID: 28221799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A generic crystallization-like model that describes the kinetics of amyloid fibril formation.
    Crespo R; Rocha FA; Damas AM; Martins PM
    J Biol Chem; 2012 Aug; 287(36):30585-94. PubMed ID: 22767606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of binding of macrocyclic metal complexes on amyloid fibrillization of insulin and lysozyme.
    Kovalska V; Chernii S; Cherepanov V; Losytskyy M; Chernii V; Varzatskii O; Naumovets A; Yarmoluk S
    J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28295701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of oligomers of heterogeneous size as precursors of amyloid fibril nucleation of an SH3 domain: an experimental kinetics study.
    Ruzafa D; Morel B; Varela L; Azuaga AI; Conejero-Lara F
    PLoS One; 2012; 7(11):e49690. PubMed ID: 23209591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly.
    Xue WF; Homans SW; Radford SE
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8926-31. PubMed ID: 18579777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R; Caflisch A
    J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
    Necula M; Kayed R; Milton S; Glabe CG
    J Biol Chem; 2007 Apr; 282(14):10311-24. PubMed ID: 17284452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly Mechanism for Aggregation of Amyloid Fibrils.
    Zhang L
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
    Ghosh P; Kumar A; Datta B; Rangachari V
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
    Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
    J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.
    Ryan TM; Teoh CL; Griffin MD; Bailey MF; Schuck P; Howlett GJ
    J Mol Biol; 2010 Jun; 399(5):731-40. PubMed ID: 20433849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
    Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
    Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and Aggregation Mechanisms in Amyloids.
    Almeida ZL; Brito RMM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32155822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular crowding favors the fibrillization of β2-microglobulin by accelerating the nucleation step and inhibiting fibril disassembly.
    Luo XD; Kong FL; Dang HB; Chen J; Liang Y
    Biochim Biophys Acta; 2016 Nov; 1864(11):1609-19. PubMed ID: 27481166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents.
    Camus MS; Dos Santos S; Chandravarkar A; Mandal B; Schmid AW; Tuchscherer G; Mutter M; Lashuel HA
    Chembiochem; 2008 Sep; 9(13):2104-12. PubMed ID: 18683159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.